Abstract:Interleukin (IL)-24 plays a potential anti-tumor activity in colorectal cancer in a dose-dependent manner. However, the immunoregulatory role of IL-24 to peripheral and tumor-infiltrating T cell function in colorectal cancer was not fully elucidated. In this study, twenty-nine colorectal adenocarcinoma patients and fifteen healthy individuals were enrolled. IL-24 expression and IL-24 receptor (IL-20R1, IL-20R2, and IL-22R1) mRNA relative level was measured by ELISA and real-time PCR, respectively. CD4+ and CD8+ T cells were purified from peripheral bloods and cancer specimens, and were stimulated with low (10 ng/ml) and high (100 ng/ml) concentration of recombinant IL-24. CD4+ T cells activity was assessed by measurement of Th cell percentage, transcriptional factors, and cytokine production. CD8+ T cells activity was evaluated by investigation of cytotoxic molecules, target cell death, and interferon-γ (IFN-γ) secretion. IL-24 was decreasingly expressed in both peripheral bloods and cancer tissues in colorectal adenocarcinoma patients. However, IL-20R1 and IL-20R2 was comparable between healthy controls and colorectal adenocarcinoma patients. Low concentration of IL-24 suppressed CD4+ T cell proliferation. In contrast, high concentration of IL-24 not only promoted CD4+ T cell proliferation, but also enhanced CD4+ T cell activity, which mainly presented as up-regulation of Th1/Th17 frequency, T-bet/RORγt mRNA, and IFN-γ/IL-17 production but down-regulation of Treg percentage, FoxP3 mRNA, and IL-10/IL-35 secretion. Moreover, high concentration of IL-24 also increased perforin and granzyme B expression in CD8+ T cells, and elevated cytolytic and non-cytolytic activity of CD8+ T cells, which presented as induction of target cell death and elevation of IFN-γ expression. However, low concentration of IL-24 did not affect bioactivity of CD8+ T cells. The current data indicated that IL-24 might regulate T cell function in a dose-dependent manner. High-concentration of IL-24 might promote anti-tumor immune responses in development novel therapeutic approaches to colorectal adenocarcinoma.

Interleukin-24 and lung cancer

Interleukin (IL)-24 Transforms the Tumor Microenvironment and Induces Anticancer Immunity in a Murine Model of Colon Cancer.

The Mechanism of Tumor Cells Apoptosis Selectively Induced by IL-24

[Research Advance of Interleukin 24].

[Mechanisms Responsible for Antitumor Activity of Melanoma Differentiation-Associated Gene -7/Interleukin-24].

Interleukin-24 Regulates T Cell Activity in Patients with Colorectal Adenocarcinoma

The clinical significance of Interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.

IL24 and Its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy.

MDA-7/IL-24 suppresses tumor adhesion and invasive potential in hepatocellular carcinoma cell lines.

Inhibitive Effect of IL-24 Gene on CD133 + Laryngeal Cancer Cells

IL-24 Gene Transfer Sensitizes Melanoma Cells to Erlotinib Through Modulation of the Apaf-1 and Akt Signaling Pathways.

The Suppression of IL-24 on Pancreatic Cancer Mediated by Tumor-Targeting Oncolytic Adenovirus in Immune-Competent Mice

Cmar_a_262745 7527..7537

Potential Implication of IL-24 in Lymphangiogenesis of Human Breast Cancer

Hypalgesia Effect of IL-24, a Quite New Mechanism for IL-24 Application in Cancer Treatment.

Antitumor Activities of Interleukin-12 in Melanoma

Interleukin-24 and its receptors.

Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth

The Role of Melanoma Differentiation-Associated Gene-7/Interleukin-24 in Epithelial Differentiation

Clinical Significance of the Interleukin 24 mRNA Level in Head and Neck Squamous Cell Carcinoma and Its Subgroups: An In Silico Investigation

A Novel Human Interleukin-24 Peptide Created by Computer-Guided Design Contributes to Suppression of Proliferation in Esophageal Squamous Cell Carcinoma Eca-109 Cells.